(Date:12/3/2009)... MELVILLE, N.Y., Dec. 3 Nikon Corporation, an ... it has signed a licensing agreement with Harvard ... Stochastic Optical Reconstruction Microscopy (STORM) technology. Under the ... enabled microscopy systems and market them with the ...
(Date:12/3/2009)... TUSTIN, Calif., Dec. 3 Peregrine Pharmaceuticals, Inc. (Nasdaq: ... results for the second quarter of fiscal year 2010 on ... a conference call and webcast to discuss the results at ... management will discuss financial results for the second quarter ended ...
(Date:12/2/2009)... 2 Martek Biosciences Corporation (Nasdaq: MATK ) announced ... fourth quarter and fiscal year 2009 on December 16, 2009, ... release, at 4:45 p.m. ET Martek will conduct a conference ... parties may listen to the call live via webcast by ...
(Date:12/2/2009)... Reportlinker.com announces that a new market research ... Drug Discovery Technologies - A Global ... ,, http://www.reportlinker.com/p0164246/Drug-Discovery-Technologies---A-Global-Update-of-Market-Trends--Opportunities.html ,, Drug discovery ... of every pharmaceutical company,s business strategy. There ...
Breaking Biology Technology:Nikon Corporation Acquires License From Harvard University For 'STORM' Super Resolution Microscopy -- Will Create Innovative New 'N-STORM' Microscope 2Nikon Corporation Acquires License From Harvard University For 'STORM' Super Resolution Microscopy -- Will Create Innovative New 'N-STORM' Microscope 3Peregrine Pharmaceuticals to Report Second Quarter FY 2010 Financial Results 2Martek to Announce Fourth Quarter and Fiscal Year 2009 Results 2Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 2Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 3Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 4Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 5Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 6Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 7Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 8Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 9... OXFORD, England, February 28, Evotec AG (Frankfurt Stock ... Phase II study for EVT 302 in smoking,cessation, ... oxidase,B (MAO-B)., This double-blind, three-way cross-over study ... on craving and withdrawal symptoms,after short-term deprivation of ...
... 28, 2008, New England Journal of Medicine, led by ... of the University of Massachusetts Medical School (UMMS), indicates ... may be the first demonstration of a link between ... of Massachusetts has offered universal newborn screening to detect ...
... LIONVILLE, Pa., Feb. 27 West Pharmaceutical,Services, Inc. (NYSE: ... a second quarter 2008 cash dividend of $0.14 per share. ... of record on April 23,2008., The Company also announced ... an average price of $40.23 per share since the,announcement of ...
Other Biology Technology:Evotec Starts Phase II in Smoking Cessation with EVT 302 2Data show a decline in cystic fibrosis since introduction of prenatal carrier screening 2...
Anti-ZFP-38/RU49 Family: Zinc Finger Peptide Sequence: SVKVEDKDFPSTCSKK...
TRIzol Reagents are ready-to-use monophasic solutions of phenol and guanidine isothiocyanate suitable for isolating total RNA DNA and proteins (16)....
Antibodies were affinity purified using epitopes specific to UBAP2L/NICE4 immobilized on solid support....
Biology Products: